SCHEMBL6637590

SCHEMBL6637590

Cc1c(NC(=O)OC(C)(C)C)ccc2nc(N(CCCc3ccccc3)C(=O)N(C)CCc3ccncc3)oc(=O)c12

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 2/20 0.49
ELANE P08246 2/20 0.49
CTSK P43235 2/20 0.37
P2RX7 Q99572 1/20 0.33
CYP17A1 P05093 2/20 0.33
TAAR1 Q96RJ0 1/20 0.32
PPARG P37231 2/20 0.31
PPARD Q03181 2/20 0.31
PPARA Q07869 2/20 0.31
GLS O94925 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
BRD4 O60885 1/20 0.30
MAPT P10636 1/20 0.30
POLB P06746 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6637653 0.96 CTRB1 (0.51) CTRB1ELANECTSKP2RX7CYP17A1
SCHEMBL6638443 0.94 CTRB1 (0.47) CTRB1ELANECTSKP2RX7MAPT
SCHEMBL6634617 0.91 CTRB1 (0.47) CTRB1ELANECTSKP2RX7NPC1
SCHEMBL6636633 0.90 CTRB1 (0.46) CTRB1ELANECTSKP2RX7CYP17A1
SCHEMBL6639583 0.90 CTRB1 (0.49) CTRB1ELANECTSKP2RX7TAAR1
SCHEMBL6639120 0.88 CTRB1 (0.47) CTRB1ELANECTSKP2RX7PPARG
SCHEMBL6636916 0.85 CTRB1 (0.50) CTRB1ELANECTSKP2RX7CYP17A1
SCHEMBL6722616 0.85 CTRB1 (0.48) CTRB1ELANECTSKP2RX7TAAR1
SCHEMBL6636983 0.85 CTRB1 (0.46) CTRB1ELANECTSKP2RX7CYP3A4
SCHEMBL6637258 0.84 CTRB1 (0.51) CTRB1ELANECTSKP2RX7CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040116420-A1 Remedial agent for viral infectious disease ASAHI KASEI PHARMA CORPORATION (JP) 2004-06-17 US disclosed
EP-1403269-A1 REMEDIAL AGENT FOR VIRAL INFECTIOUS DISEASE Asahi Kasei Pharma Corporation (JP) 2004-03-31 EP disclosed